â¢ Aspirin: its effectiveness in prevention has consistently demonstrated to be lower than that of other thromboprophylaxis systems, for this reason the ACCP does not recommend its use.
Aspirina: su efectividad en la prevención ha demostrado consistentemente ser inferior a la de otros sistemas de tromboprofilaxis, por ello el ACCP no recomienda su uso.